TP53 and neoplasm: Within the TME, the loss of wild-type p53 promotes the recruitment of tumor-supportive myeloid cells, while the presence of mutant p53 leads to the development of highly suppressive Treg populations (Bezzi et al., 2018; Togashi et al., 2019; Blagih et al., 2020).